COMMUNIQUÉS West-GlobeNewswire

Les données du système LithiX HC – IVL d’Elixir Medical démontrent une sécurité et une efficacité prolongées après six mois
30/10/2024
Les données du système LithiX HC – IVL d’Elixir Medical démontrent une sécurité et une efficacité prolongées après six mois —Données des essais cliniques PINNACLE I d’Elixir dans la fragmentation des calcifications [...]
Comprehensive Healthcare launches “What we do means more” recruitment campaign highlighting rewarding careers in community behavioral health
30/10/2024
YAKIMA, Wash., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Access to quality community behavioral healthcare is life-changing for adults, families and youth facing mental health challenges. Being a part of the team that delivers [...]
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
28/10/2024
BRISBANE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with [...]
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
28/10/2024
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with [...]
NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November
28/10/2024
NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
28/10/2024
SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing [...]
Certara to Participate in the Stephens Annual Investment Conference
28/10/2024
RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the Stephens Annual Investment [...]
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28/10/2024
CARSON CITY, Nev., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
Inari Medical Reports Third Quarter 2024 Financial Results
28/10/2024
IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
28/10/2024
GAITHERSBURG, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
28/10/2024
Ninety percent of survey participants reported “some” or “significant” negative impact of IBS-C on their life Survey results presented in two poster presentations WALTHAM, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/10/2024
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
28/10/2024
WILMETTE, Ill., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments [...]
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28/10/2024
CARSON CITY, Nev., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]
Sonablate announces first patient enrolled in HIFIVE U.S. clinical trial for ablation of incompetent veins
28/10/2024
HIFIVE is a single arm, single institution, Phase I trial to assess the safety and performance of Sonablate high-intensity focused ultrasound for treating incompetent veins including vascular malformations CHARLOTTE, N. [...]
Elixir Medical’s DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months
28/10/2024
Elixir Medical’s DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months —Late-breaking 12-month [...]
Après six mois, le DynamX Bioadaptor d’Elixir Medical fait preuve d’une amélioration importante en comparaison des stents à élution médicamenteuse (DES), chez les patients atteints de syndrome coronarien aigu et de lésions complexes
28/10/2024
Après six mois, le DynamX Bioadaptor d’Elixir Medical fait preuve d’une amélioration importante en comparaison des stents à élution médicamenteuse (DES), chez les patients atteints de syndrome coronarien aigu et de [...]
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
28/10/2024
Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and [...]
Oxford Treatment Center Leads the Way in Delivering Veteran Ready Care with New PsychArmor Certification
28/10/2024
ETTA, Miss., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Oxford Treatment Center has joined a small group of addiction treatment providers across the nation that have achieved Veteran Ready Certification from PsychArmor, a [...]

Pages